A detailed history of Amalgamated Bank transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 865 shares of LRMR stock, worth $3,287. This represents 0.0% of its overall portfolio holdings.

Number of Shares
865
Previous 865 -0.0%
Holding current value
$3,287
Previous $6,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$4.2 - $13.28 $5,762 - $18,220
-1,372 Reduced 61.33%
865 $7,000
Q4 2023

Feb 06, 2024

SELL
$2.35 - $4.71 $603 - $1,210
-257 Reduced 10.3%
2,237 $10,000
Q2 2023

Aug 11, 2023

BUY
$3.13 - $5.27 $7,806 - $13,143
2,494 New
2,494 $7,000

Others Institutions Holding LRMR

About Larimar Therapeutics, Inc.


  • Ticker LRMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,269,200
  • Market Cap $164M
  • Description
  • Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...
More about LRMR
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.